These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3512896)

  • 1. [Characteristics of the water-electrolyte metabolism of hypertension patients with stable hypertension and the principles of diuretic therapy].
    Nekrasova AA; Suvorov IuI; Chernova NA; Zharova EA; Nesterova AL
    Kardiologiia; 1986 Jan; 26(1):27-34. PubMed ID: 3512896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of diuretics on the humoral system of kidney prostaglandins in hypertension patients].
    Nekrasova AA; Dzhusipov AK
    Kardiologiia; 1984 Sep; 24(9):98-104. PubMed ID: 6596457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal PGs in essential hypertension; the role of water-electrolyte shifts in their metabolism.
    Nekrasova AA; Levitskaya YuV
    Biomed Biochim Acta; 1984; 43(8-9):S251-4. PubMed ID: 6596098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinins and prostaglandins in hypertension.
    Abe K
    Clin Endocrinol Metab; 1981 Nov; 10(3):577-605. PubMed ID: 6284417
    [No Abstract]   [Full Text] [Related]  

  • 5. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in urinary prostaglandin excretion in hypertension patients undergoing variants of furosemide administration].
    Dzhusipov AK; Nekrasova AA
    Ter Arkh; 1984; 56(4):90-4. PubMed ID: 6587605
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium chloride as regulator of renal prostaglandin E2 production in patients with essential hypertension.
    Stahl RA; Jonassen AJ; Paravicini M; Schollmeyer P
    Klin Wochenschr; 1982 Jun; 60(11):579-81. PubMed ID: 7050523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of prostaglandin E2, prostaglandin F2 alpha, and thromboxane B2 in normotensive and hypertensive subjects on varying sodium intakes.
    Campbell WB; Holland OB; Adams BV; Gomez-Sanchez CE
    Hypertension; 1982; 4(5):735-41. PubMed ID: 7049923
    [No Abstract]   [Full Text] [Related]  

  • 9. [Renal prostaglandins and hypertension].
    Nekrasova AA; Klembovskiĭ AA; Levitskaia IuV; Dzhusipov AK; Akhmetov MA
    Kardiologiia; 1986 Mar; 26(3):13-20. PubMed ID: 3458967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Restructuring of the endocrine function of the kidney in hypertension].
    Nekrasova AA
    Kardiologiia; 1981 Jul; 21(7):13-20. PubMed ID: 7024615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathophysiologic role of the level of taste sensitivity to table salt and its determination during treatment of hypertension with diuretics].
    Nekrasova AA; Suvorov IuI; Musaev ZM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):68-72. PubMed ID: 6732935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in body fluid spaces in hypertension patients treated with different diuretics].
    Shkhvatsabaia IK; Musaev ZM; Nekrasova AA; Suvorov IuI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):62-8. PubMed ID: 6732934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional rearrangement of the renal endocrine system in patients with hypertension].
    Shkhvatsabaia IK; Nekrasova AA
    Kardiologiia; 1983 Dec; 23(12):12-7. PubMed ID: 6583459
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of atenolol treatment on urinary prostaglandins E2 and F2 alpha in essential hypertension.
    Rathaus M; Magen A; Rath-Wolfson L; Shapira J; Bernheim J
    Isr J Med Sci; 1983 Dec; 19(12):1072-4. PubMed ID: 6582055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic and endocrine responses of the kidney to frusemide in mild essential hypertension.
    Mackay IG; Nath K; Cumming AD; Muir AL; Watson ML
    Clin Sci (Lond); 1985 Feb; 68(2):159-64. PubMed ID: 3881208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered renal prostaglandin production after sodium loading in hypertensive patients.
    Neri Serneri GG; Castellani S; Scarti L; Trotta F; Sciagrà R; Masotti G
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():203-8. PubMed ID: 3159204
    [No Abstract]   [Full Text] [Related]  

  • 18. Initial mechanisms in hypertension after bilateral renal ischemia in the rat.
    de la Riva IJ; Morera S; Rosón MI; Mon MD; Basso N; Taquini AC
    Hypertension; 1981; 3(6 Pt 2):II-205-10. PubMed ID: 7028618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal prostaglandins in borderline and sustained essential hypertension.
    Lebel M; Grose JH
    Prostaglandins Leukot Med; 1982 May; 8(5):409-18. PubMed ID: 7048332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of prostaglandin E like material and kallikrein: effects of furosemide.
    Halushka PV; Margolius HS; Allen H; Conradi EC
    Prostaglandins; 1979 Sep; 18(3):359-68. PubMed ID: 260996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.